Clinical practice guidelines for prophylaxis of venous thomboembolism in cancer patients - Aix-Marseille Université Access content directly
Journal Articles Thrombosis and Haemostasis Year : 2016

Clinical practice guidelines for prophylaxis of venous thomboembolism in cancer patients

Abstract

Symptomatic venous thromboembolism (VTE) occurs 4-7 times more frequently in cancer patients as compared to non-cancer patients. A significant number of risk factors, which can be subcategorised as patient-, cancer- or treatment-related, have been shown to influence the risk of VTE during malignancy and further incorporated in risk-assessment models. Safe and efficient thromboprophylaxis regimens allow substantial decreased in VTE rates, since VTE is most often a largely preventable disease, but thromboprophylaxis remains underused in cancer compared to non-cancer patients. If thromboprophylaxis is warranted in cancer patients undergoing surgery or hospitalised for acute medical illness or with a lower mobility in the absence of contraindications to anticoagulants, its benefit remains controversial in outpatients and may be limited to locally advanced or metastatic pancreatic or lung cancer treated with chemotherapy. The International Initiative on Thrombosis and Cancer-CME free mobile app (ios and android), based on the International Clinical Practice Guidelines (CPG), facilitates their implementation and dissemination of knowledge worldwide so as to improve VTE treatment and prophylaxis in cancer patients.
No file

Dates and versions

hal-01451033 , version 1 (31-01-2017)

Identifiers

Cite

Corinne Frere, Dominique Farge. Clinical practice guidelines for prophylaxis of venous thomboembolism in cancer patients. Thrombosis and Haemostasis, 2016, 116 (4), pp.618-625. ⟨10.1160/TH16-04-0302⟩. ⟨hal-01451033⟩
20 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More